Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kudu Biomass Group is a Namibian joint venture focused on the sustainable production and export of high-quality charcoal, including restaurant-grade charcoal for European markets. The company utilizes mechanized selective thinning of encroached rangeland and in-field whole-tree processing to produce billets, which are then converted to lump charcoal using clean, efficient centralized retort technology. There is no evidence that the company operates in life sciences, biotech, pharma, or healthcare sectors[2][1].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kudu Biomass Group.